The Brigham and Dana-Farber Board Review in Hematology and Oncology 2020

Improve Patient Care in Hematology and Oncology

The Brigham and Dana-Farber Board Review in Hematology and Oncology will help improve clinical practice gaps in hematology and oncology derived from the American Board of Internal Medicine (ABIM) certification/recertification requirements. In this CME program, expert speakers address relevant topics in case-based board review presentations. Improve patient care by learning to:

• Perform differential diagnosis of complex hematologic and oncologic disorders
• Identify and apply current therapeutic options for hematologic and oncologic disorders
• Evaluate and interpret up-to-date literature relevant to hematology and oncology
• Illustrate knowledge of pathophysiology of hematologic and oncologic disorders
• Apply new knowledge to the ABIM certification/recertification hematology and oncology examinations

Discover New Guidelines

This learn-at-your-own-pace course in hematology and oncology provides a maximum of 44 AMA PRA Category 1 Credits ™ and 44 ABIM MOC points. Available online or via audio MP3 CDs, it provides access to unbiased, evidence-based content and case-based reviews so you can expand your knowledge and incorporate the latest guidelines into your daily practice

 

TOPICS/SPEAKERS

• Molecular Genetics of Cancer – Nikhil Wagle, MD

• Advances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD

• Infections in Cancer Patients – Lindsey Baden, MD

• Symptom Management in Patients with Cancer – Andrew J. Lawton, MD

• Communication: The Key to Excellence in End-of-Life Care – Rachelle E. Bernacki, MD

• Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD

• Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD

• Acute Leukemias – Daniel J. DeAngelo, MD, PhD

• Myelodysplastic Syndrome – David P. Steensma, MD

• Chronic Myelogenous Leukemia – Marlise R. Luskin, MD

• Myeloproliferative Syndromes – Ann M. Mullally, MD

• Multiple Myeloma – Kenneth C. Anderson, MD

• Waldenstrom Macroglobulemia and Amyloidosis – Jorge J. Castillo, MD

• Low Grade Lymphomas – Caron A. Jacobson, MD

• High Grade Lymphomas – Eric D. Jacobsen, MD

• Hodgkin’s Lymphoma – Jennifer L. Crombie, MD

• Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD

• Head and Neck Cancer – Robert I. Haddad, MD

• Natural History, Screening, Surgery and Small Cell Lung Cancer – Bruce E. Johnson, MD

• Non Small Cell Lung Cancer – Mark Awad, MD, PhD

• Mesothelioma and Thymoma – David M. Jackman, MD

• Thyroid Cancer – Jochen Lorch, MD

• Carcinoid and Pancreatic Neuroendocrine Tumors – Jennifer Ang Chan, MD

• Esophageal and Gastric Cancer – Peter C. Enzinger, MD

• Pancreatic and Hepatobiliary Cancer – Brian M. Wolpin, MD

• Anal Cancers – Robert J. Mayer, MD

• Colorectal Cancers – Robert J. Mayer, MD

• Gastrointestinal Cancer: Genetic Syndromes – Matthew Yurgelun, MD

• Germ Cell Tumor: Maximizing Cure While Minimizing the Burden of Therapy – Mark M. Pomerantz, MD

• Renal and Bladder Cancer – Guru P. Sonpavde, MBBS

• Prostate Cancer Part I: Overview and Management of Localized Disease – Atish D. Choudhury, MD, PhD

• Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish D. Choudhury, MD, PhD

• Melanoma – F. Stephen Hodi, MD

• Sarcomas and Gastrointestinal Stromal Tumors (GIST) – George D. Demetri, MD

• Ovarian Cancer – Ursula A. Matulonis, MD

• Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD

• Neuro-oncology – David A. Reardon, MD

• Breast Cancer: Risk Factors, Genetics, Screening, and Prevention – Judy E. Garber, MD, MPH

• Multimodality Therapy for Early Stage Breast Cancer: Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD

• Multimodality Therapy for Early Stage Breast Cancer: Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD

• Management of Metastatic Breast Cancer – Erica Mayer, MD, MPH

• Breast Cancer Survivorship – Ann H. Partridge, MD, MPH

• Hematopoiesis and Cytokines – David T. Scadden, MD

• Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD

• Congenital Bone Marrow Failure – Akiko Shimamura, MD, PhD

• Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD

• Anemia: An Overview – Ronald P. McCaffrey, MD

• Iron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD

• Immune Hemolytic Anemia – Richard M. Kaufman, MD

• Non-immune Hemolytic Anemia – David E. Golan, PhD, MD

• Sickle Cell Disease – Maureen M. Achebe, MD, MPH

• Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD

• Disorders of Neutrophils – Nancy Berliner, MD

• Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD

• Hemophilia – Aric D. Parnes, MD

• Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH

• Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD

• Use of Direct Oral Anticoagulants in Clinical Practice – Jean M. Connors, MD

• Transfusion Medicine for the Clinician – Walter H. Dzik, MD

Date of Original Release: April 15, 2020
Termination Date: April 15, 2023